台股 » 個股 » 中化生 » 籌碼相關 » 融資融券與借券

中化生

(1762)
可現股當沖
  • 股價
    34.00
  • 漲跌
    ▼1.65
  • 漲幅
    -4.63%
  • 成交量
    388
  • 產業
    上市 生技醫療類股
  • 251人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中化生 (1762) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

中化生 (1762) 融資融券與借券

中化生 (1762) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
12/13-11,4707.58-4330.17002.2434-4.63%388
12/12-121,4717.591370.19002.5235.65-0.70%138
12/11-221,4837.653360.19002.4335.9-2.58%256
12/10-531,5057.760330.17002.1936.85-1.07%116
12/09-251,5588.040330.17002.1237.25-0.67%118
12/0611,5838.16-1330.17002.0837.5-0.13%123
12/0561,5828.160340.18002.1537.55-1.57%106
12/0401,5768.130340.18002.1638.15-0.13%60
12/03-41,5768.130340.18002.1638.2-0.26%50
12/02-41,5808.152340.18002.1538.30.26%70
11/29-71,5848.171320.17002.0238.20.92%75
11/2861,5918.210310.16001.9537.85-1.82%112
11/27-91,5858.170310.16001.9638.550.00%67
11/2621,5948.221310.16001.9438.550.39%43
11/25-61,5928.210300.15001.8838.40.26%119
11/22-131,5988.240300.15001.8838.3-0.13%118
11/2161,6118.310300.15001.8638.35-0.13%81
11/20-61,6058.28-1300.15001.8738.4-0.39%64
11/19-71,6118.31-1310.16001.9238.550.13%53
11/18-51,6188.34-1320.17001.9838.50.13%78
11/1571,6238.37-2330.17002.0338.45-0.13%168
11/14121,6168.33-6350.18002.1738.5-5.87%488
11/13131,6048.27-16410.21002.5640.9-1.21%151
11/12-121,5918.21-46570.29003.5841.4-1.43%148
11/1101,6038.2701030.53006.4342-1.41%109
11/08-41,6038.27191030.53006.4342.6-0.47%83
11/07-41,6078.2930840.43005.2342.81.18%187
11/0621,6118.3133540.28003.3542.3-0.70%75
11/05-51,6098.32210.11001.3142.60.83%76
11/04-41,6148.320190.1001.1842.25-1.29%89
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
12/13400-433@Limit20.17150-41,17034-4.63%388
12/12010137@Limit20.1910011,17435.65-0.70%138
12/11030336@Limit20.1900001,17335.9-2.58%256
12/10000033@Limit20.1700001,17336.85-1.07%116
12/09000033@Limit20.17010-11,17337.25-0.67%118
12/06210-133@Limit20.17070-71,17437.5-0.13%123
12/05000034@Limit20.1800001,18137.55-1.57%106
12/04000034@Limit20.181220-211,18138.15-0.13%60
12/03000034@Limit20.18070-71,20238.2-0.26%50
12/02020234@Limit20.180160-161,20938.30.26%70
11/29010132@Limit20.1700001,22538.20.92%75
11/28000031@Limit20.160310-311,22537.85-1.82%112
11/27000031@Limit20.160700-701,25638.550.00%67
11/26010131@Limit20.1600001,32638.550.39%43
11/25000030@Limit20.1500001,32638.40.26%119
11/22000030@Limit20.1501000-1001,32638.3-0.13%118
11/21000030@Limit20.150320-321,42638.35-0.13%81
11/20100-130@Limit20.1500001,45838.4-0.39%64
11/19100-131@Limit20.160320-321,45838.550.13%53
11/18100-132@Limit20.1711001,49038.50.13%78
11/15200-233@Limit20.1720021,49038.45-0.13%168
11/14600-635@Limit20.187680-611,48838.5-5.87%488
11/1326100-1641@Limit20.2100001,54940.9-1.21%151
11/124600-4657@Limit20.291310-301,54941.4-1.43%148
11/110000103@Limit20.534210-171,57942-1.41%109
11/08019019103@Limit20.531150-141,59642.6-0.47%83
11/0703003084@Limit20.4310011,61042.81.18%187
11/0603303354@Limit20.281690-681,60942.3-0.70%75
11/05020221@Limit20.110210-211,67742.60.83%76
11/04000019@Limit20.101060-1061,69842.25-1.29%89
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
12/13511,728,2501,758,70013.14597.06
12/1211394,750393,2507.97-136.36
12/118288,000288,5503.1368.75
12/1010370,850369,5508.62-130
12/0912446,050448,40010.17195.83
12/063112,500112,9002.44133.33
12/054150,850151,1003.7762.5
12/044152,950152,8506.67-25
12/033114,450114,8006116.67
12/024152,800154,0005.71300
11/298302,300302,65010.6743.75
11/286227,350229,8005.36408.33
11/273115,600115,6004.480
11/266230,550230,90013.9558.33
11/2511422,150422,8509.2463.64
11/2216615,100614,85013.56-15.63
11/21138,30038,3501.2350
11/20276,70076,6503.13-25
11/195192,700193,3009.43120
11/184153,850154,0005.1337.5
11/1516614,150617,0009.52178.13
11/14783,053,3503,092,45015.98501.28
11/138329,300328,7005.3-75
11/1210414,400415,0006.7660
11/119376,100379,0508.26327.78
11/086255,600255,9507.2358.33
11/07241,012,1001,020,95012.83368.75
11/065212,300211,8506.67-90
11/054170,500170,3005.26-50
11/043127,000126,7503.37-83.33
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章